Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.

Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ.

Pediatr Infect Dis J. 2009 May;28(5):398-402. doi: 10.1097/INF.0b013e3181906e40.

2.

Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation.

Frymoyer A, Hersh AL, Coralic Z, Benet LZ, Joseph Guglielmo B.

Clin Ther. 2010 Mar;32(3):534-42. doi: 10.1016/j.clinthera.2010.03.005.

3.

Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.

Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD.

Int J Antimicrob Agents. 2014 Feb;43(2):179-83. doi: 10.1016/j.ijantimicag.2013.10.017. Epub 2013 Nov 18.

PMID:
24315788
4.
5.

Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.

Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD.

Int J Antimicrob Agents. 2015 Dec;46(6):689-95. doi: 10.1016/j.ijantimicag.2015.09.010. Epub 2015 Oct 17.

PMID:
26555059
6.

Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.

Frymoyer A, Guglielmo BJ, Hersh AL.

Pediatr Infect Dis J. 2013 Oct;32(10):1077-9. doi: 10.1097/INF.0b013e318299f75c.

PMID:
23652479
7.

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ.

Clin Pharmacokinet. 2004;43(13):925-42.

PMID:
15509186
8.

Vancomycin AUC24 /MIC Ratio in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia.

Ji M, Kim HK, Kim SK, Lee W, Sung H, Chun S, Kim MN, Min WK.

J Clin Lab Anal. 2016 Sep;30(5):485-9. doi: 10.1002/jcla.21883. Epub 2015 Oct 26.

PMID:
26499918
9.

Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.

Fukumori S, Tsuji Y, Mizoguchi A, Kasai H, Ishibashi T, Iwamura N, To H.

J Clin Pharm Ther. 2016 Aug;41(4):399-402. doi: 10.1111/jcpt.12399. Epub 2016 May 4.

PMID:
27144370
10.

Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow-fiber infection model.

Nicasio AM, Bulitta JB, Lodise TP, D'Hondt RE, Kulawy R, Louie A, Drusano GL.

Antimicrob Agents Chemother. 2012 Feb;56(2):682-6. doi: 10.1128/AAC.05664-11. Epub 2011 Nov 14.

13.

[Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].

Lepe JA, Gil-Navarro MV, Santos-Rubio MD, Bautista J, Aznar J.

Rev Esp Quimioter. 2010 Mar;23(1):43-7. Spanish.

14.

Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?

Lodise TP, Drusano GL, Zasowski E, Dihmess A, Lazariu V, Cosler L, McNutt LA.

Clin Infect Dis. 2014 Sep 1;59(5):666-75. doi: 10.1093/cid/ciu398. Epub 2014 May 27.

PMID:
24867791
15.

Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.

Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL.

Pharmacotherapy. 2011 Sep;31(9):871-6. doi: 10.1592/phco.31.9.871.

16.

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.

Arch Intern Med. 2006 Oct 23;166(19):2138-44.

PMID:
17060545
17.

Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.

Lim HS, Chong YP, Noh YH, Jung JA, Kim YS.

J Clin Pharm Ther. 2014 Apr;39(2):196-203. doi: 10.1111/jcpt.12123. Epub 2014 Jan 16.

PMID:
24428720
18.
19.

[Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].

Çıkman A, Aydın M, Gülhan B, Parlak M, Gültepe B, Kalaycı Y, Bayındır Bilmen F, Solmaz S, Özekinci T.

Mikrobiyol Bul. 2015 Apr;49(2):240-8. Turkish.

20.

Supplemental Content

Support Center